Sotatercept might help treat portopulmonary hypertension

Robyn Kalda
Mar 2
1 min read

Patients with portopulmonary hypertension were not included in clinical trials for sotatercept. This case report found that sotatercept helped one patient with portopulmonary hypertension, who was then able to get a liver transplant. However, they did note some risks.

Read the Communications Medicine article

Recent Posts

Endoplasmic reticulum stress induces a pathway that accelerates PAH progression

This study found that endoplasmic reticulum stress in lung blood vessels may contribute to pulmonary arterial hypertension (PAH) by triggering pyroptosis and damaging blood vessels. In rats, blocking

Phase 3 ADVANCE OUTCOMES trial on ralinepag succeeds

Patients with pulmonary arterial hypertension who took ralinepag in addition to their usual treatment were less likely to have their disease get worse than those who took a placebo. However, more peop

More severe functional limitations are associated with higher social isolation

Functional disability, but not chronic disease category or chronic pain, was independently associated with lower social support. Social isolation among Canadian adults is more closely associated with

Comments

Couldn’t Load Comments

It looks like there was a technical problem. Try reconnecting or refreshing the page.